A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes with and without Ibalizumab in a Real-World Setting: United States (PROMISE-US) Study Design and Baseline Characteristics

Dec 31, 2024 31 Dec 2024 at 5:00 PM EST

Kumar, P. , Rolle, C., Henry, Z., Emu, B., Martorell, C., McKinnon, J., Slim, J., Cash, R. B. and Anstett, K., on behalf of the PROMISE-US Investigators